About HERCEPTIN

HERCEPTIN is a prescription medication containing the active ingredient Trastuzumab, a recombinant humanized monoclonal antibody. It is used in the treatment of certain types of breast cancer, specifically HER2-positive breast cancer, which is characterized by the presence of excess HER2 protein on the surface of cancer cells.

Key Benefits & Uses

Treatment of HER2-positive breast cancer in patients with early-stage or metastatic disease
Adjuvant treatment of HER2-positive breast cancer in patients with residual invasive disease after neoadjuvant chemotherapy
Neoadjuvant treatment of HER2-positive breast cancer in patients with locally advanced disease

Active Ingredient & Action

Trastuzumab works by binding to the HER2 protein on the surface of cancer cells, which can help to slow or stop the growth of the cancer. By targeting the HER2 protein, Trastuzumab can help to reduce the size of tumors and prevent the spread of cancer to other parts of the body.

Important Notes

HERCEPTIN should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of side effects. Patients with a history of heart disease or other cardiovascular conditions should be closely monitored while receiving HERCEPTIN treatment.